by The Protein A Resin Market is estimated to be valued at US$ 474.0 Mn in 2019 and is expected to exhibit a CAGR of 8.5% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Protein A Resin Market comprises of resins that are commonly used for the purification of monoclonal antibodies (mAbs) in biopharmaceutical production. Protein A resin provides high binding capacity, high selectivity, and improved purity of mAbs. The use of mAbs has witnessed substantial growth in recent years due to their specificity and therapeutic potential. The increasing demand for monoclonal antibodies and the rising focus on therapeutic antibody development are key factors driving the protein A resin market.
Market Dynamics:
The protein A resin market is driven by the growing demand for monoclonal antibodies in various applications, including oncology, immunology, and infectious diseases. Monoclonal antibodies are widely used for targeted therapy as they can selectively bind to specific antigens. The rising prevalence of chronic diseases and the increasing adoption of personalized medicine are further driving the demand for mAbs, thereby fueling the growth of the protein A resin market.
Additionally, advancements in bioprocessing technologies and the increasing investments in research and development activities are expected to propel market growth. Growing government initiatives and funding for biopharmaceutical research is also expected to create lucrative opportunities for market players in the protein A resin market.
Segment Analysis:
The Protein A Resin market can be segmented based on product type, application, and end-user. In terms of product type, the Protein A Resin market is dominated by natural protein A resin. This segment is expected to hold the largest market share due to its high affinity and specificity for IgG antibodies. Natural protein A resin is widely used in the purification of monoclonal antibodies, which are extensively used in diagnostics and therapeutic applications. The dominating sub-segment within this category is agarose-based protein A resin, owing to its high capacity and excellent mechanical stability.
PEST Analysis:
Political: The Protein A Resin Market Size is subject to government regulations and policies related to the healthcare industry. Government support and funding for research and development in the biopharmaceutical sector can impact the market.
Economic: Increasing investments in biopharmaceutical research and development, along with the growing demand for monoclonal antibodies, are driving the growth of the Protein A Resin market. The market is also influenced by economic factors such as inflation, exchange rates, and healthcare expenditure.
Social: Growing awareness about personalized medicine and the increasing prevalence of chronic diseases are fueling the demand for biopharmaceutical products, including monoclonal antibodies. This social trend is driving the growth of the Protein A Resin market.
Technological: Advancements in protein purification techniques and the development of novel Protein A Resin products are enhancing the efficiency and effectiveness of purification processes. Technological innovations such as the use of single-use Protein A Resin cartridges are gaining traction in the market.
Key Takeaways:
The global Protein A Resin market is expected to witness high growth, exhibiting a CAGR of 8.5% over the forecast period. The increasing demand for monoclonal antibodies, coupled with advancements in protein purification techniques, is driving market growth. The market is dominated by natural protein A resin, specifically agarose-based resin, due to its high affinity and capacity for IgG antibodies.
In terms of regional analysis, North America is the fastest-growing and dominating region in the Protein A Resin market. This can be attributed to the presence of key players, such as GE Healthcare and Thermo Fisher Scientific, and the high adoption of biopharmaceutical products in the region.
Key players operating in the Protein A Resin market are GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. These companies have a strong presence in the market and are focusing on product development and expansion strategies to maintain their market position.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
